A life-saving meningococcal vaccine covering all five common strains of the deadly disease could soon be available thanks to ...

In February 2010, a quadrivalent conjugate vaccine (Menveo; Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis ...

Effective vaccines are available against the ACWY groups (MenACWY), alongside ... “There is an inconsistent approach towards meningococcal vaccine implementation,” says Masignani.

The advice is for all new university entrants up to the age of 25 to be vaccinated with the Meningococcal ACWY (MenACWY) vaccine before the beginning of the new academic year. Students are advised to ...

In this report, we summarize the findings of 10 phase 3 and 4 clinical studies evaluating coadministration of the quadrivalent meningococcal ... coadministered with ACWY, compared with when ...

The meningococcal ACWY vaccine is scheduled for children and adolescents from 11 to 14 years old, and immunization in this age group is important to contain circulation since adolescents and young ...

2 In another vote, ACIP recommended Penmenvy as an alternative to separate meningococcal group ACWY and meningococcal group B (MenB) vaccinations when both are administered during the same visit for ...

Meningococcal meningitis is a serious bacterial infection that causes infection of the tissue surrounding the brain and spinal cord. Most people recover from meningitis, however, serious complications ...

ACIP voted to recommend that persons over 10 years old receive a single dose of PENMENVY as an alternative to separate administration of meningococcal serogroups A, C, W, and Y (MenACWY ...

. The global meningococcal vaccines market size is anticipated to grow nearly 2X, expanding from USD 4.53 Bn in 2025 to USD 9.05 Bn by 2032, recording a CAGR of 10.4% throughout the forecast ...